HEPA
Hepion Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.10
−1.45%Next report
Analyst consensus
- Next report date
- Mar 3, 2027
- EPS estimate
- -$190
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.08
- EPS estimate
- -$200
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +67.5%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$200 | -$0.08 | Beat 99.96% | — |
| May 14, 2026 | -$200 | -$0.07 | Beat 99.97% | — |
| Mar 11, 2026 | — | -$0.07 | — | — |
| Nov 12, 2025 | — | -$0.04 | — | — |
| Aug 15, 2025 | — | -$0.09 | — | — |
| May 19, 2025 | — | -$2.15 | — | — |
| Nov 14, 2024 | -$95 | -$36 | Beat 62.11% | — |
| Apr 16, 2024 | -$132 | -$121 | Beat 7.98% | — |
| Nov 20, 2023 | -$134 | -$137 | Miss -2.24% | — |
| Aug 14, 2023 | -$3.32 | -$184 | Miss -5442.17% | — |
| May 12, 2023 | -$3.60 | -$174 | Miss -4733.33% | — |
| Nov 14, 2022 | -$0.17 | -$110 | Miss -64605.88% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 3, 2027